[1] Umer, Amna et al. “The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure.” Stem cell reviews and reports vol. 19,3 (2023): 651-666. doi:10.1007/s12015-022-10493-yIF: 4.8 Q2
[2] Zhang, Y.; Shi, L.; Lin, X.; Zhou, F.; Xin, L.; Xu, W.; Yu, H.; Li, J.; Pan, M.; Pan, Y.; et al. Unresponsive thin endometrium caused by Asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: A pilot study. Stem Cell Res. Ther. 2021, 12, 420.
[3] Zhao, Y.; Luo, Q.; Zhang, X.; Qin, Y.; Hao, J.; Kong, D.; Wang, H.; Li, G.; Gu, X.; Wang, H. Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis. Stem Cells Int. 2020, 2020, 8820538.
[4] Tan, J.; Li, P.; Wang, Q.; Li, Y.; Li, X.; Zhao, D.; Xu, X.; Kong, L. Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Hum. Reprod. 2016, 31, 2723–2729.
[5] Ma, H.; Liu, M.; Li, Y.; Wang, W.; Yang, K.; Lu, L.; He, M.; Deng, T.; Li, M.; Wu, D. Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion. J. Obstet. Gynaecol. Res. 2020, 46, 2347–2355.
[6] Chugh, R.M.; Park, H.S.; Esfandyari, S.; Elsharoud, A.; Ulin, M.; Al-Hendy, A. Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2. Int. J. Mol. Sci. 2021, 22, 9184.
[7] Prayitno, G.D.; Lestari, K.; Sartika, C.R.; Djuwantono, T.; Widjaya, A.; Muharam, R.; Hidayat, Y.M.; Wulandari, D.; Haifa, R.; Naura, N.F.; et al. Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review. Medicines 2022, 10, 3.
[8] Xie, Q.; Xiong, X.; Xiao, N.; He, K.; Chen, M.; Peng, J.; Su, X.; Mei, H.; Dai, Y.; Wei, D.; et al. Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int. 2019, 2019, 9782373.
[9] Gabr, H.; Elkheir, W.A.; El-Gazzar, A. Autologus stem cell transplantation in patients with idiopathic premature ovarian failure. J. Tissue Sci. Eng. 2016, 7, 27.
[10] Xu, T.; Yu, X.; Yang, Q.; Liu, X.; Fang, J.; Dai, X. Autologous Micro-Fragmented Adipose Tissue as Stem Cell-Based Natural Scaffold for Cartilage Defect Repair. Cell Transplant. 2019, 28, 1709–1720.
[11] Casarotti, G.; Tremolada, C. A new treatment of genito-urinary post-menopausal atrophy with autologous micro-fragmented fat tissue: A thirty-six months follow up case series. Eur. Rev. Med. Pharmacol. Sci. 2020, 24, 7420–7426.
[12] Li J, Xiong M, Fu XH, Fan Y, Dong C, Sun X, Zheng F, Wang SW, Liu L, Xu M, Wang C, Ping J, Che S, Wang Q, Yang K, Zuo Y, Lu X, Zheng Z, Lan T, Wang S, Ma S, Sun S, Zhang B, Chen CS, Cheng KY, Ye J, Qu J, Xue Y, Yang YG, Zhang F, Zhang W, Liu GH. Determining a multimodal aging clock in a cohort of Chinese women. Med. 2023 Jul 24:S2666-6340(23)00197-6. doi: 10.1016/j.medj.2023.06.010. Epub ahead of print. PMID: 37516104.
[13] https://www.mdpi.com/1422-0067/18/1/208#B67-ijms-18-00208
[14] 韓曉瑾.間充質干細胞修復盆底功能障礙性疾病的進展[J].中國婦幼健康研究,2019,(12):1612-1616.
[15] Klapper-Goldstein H, Tamam S, Sade S, Weintraub AY. A systematic review of stem cell therapy treatment for women suffering from stress urinary incontinence. Int J Gynaecol Obstet. 2022 Apr;157(1):19-30. doi: 10.1002/ijgo.13769. Epub 2021 Jul 17. PMID: 34048059.
